Neoadjuvant chemotherapy vs chemoradiotherapy for locally advanced gastric cancer: A propensity score-matched study
World Journal of Gastrointestinal Oncology · 30.10.2026
DOI: 10.4251/wjgo.125732 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Oncology, online erschienen am 30.10.2026. Verfasst von Yi-Fan Wang und 13 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, Y., Qiao, X., Liu, Q., Song, Y., Fang, H., Chen, B., Lu, N., Qi, S., Jing, H., Wang, S., Li, Y., Jin, J., Tang, Y., & Li, N. (2026). Neoadjuvant chemotherapy vs chemoradiotherapy for locally advanced gastric cancer: A propensity score-matched study. World Journal of Gastrointestinal Oncology. https://doi.org/10.4251/wjgo.125732
Vancouver
Wang Y, Qiao X, Liu Q, Song Y, Fang H, Chen B, et al. Neoadjuvant chemotherapy vs chemoradiotherapy for locally advanced gastric cancer: A propensity score-matched study. World Journal of Gastrointestinal Oncology. 2026. doi:10.4251/wjgo.125732
BibTeX
@article{Wang2026,
author = {Wang, Yi-Fan and Qiao, Xia-Xi and Liu, Quan-Ming and Song, Yong-Wen and Fang, Hui and Chen, Bo and Lu, Ning-Ning and Qi, Shu-Nan and Jing, Hao and Wang, Shu-Lian and Li, Ye-Xiong and Jin, Jing and Tang, Yuan and Li, Ning},
title = {Neoadjuvant chemotherapy vs chemoradiotherapy for locally advanced gastric cancer: A propensity score-matched study},
journal = {World Journal of Gastrointestinal Oncology},
year = {2026},
doi = {10.4251/wjgo.125732}
}
EUVIMED